The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[2-oxo-2-(1,2,3,4-tetrahydronaphthalen-1-ylamino)ethyl]quinoline-6-carboxamide ID: ALA3717713
PubChem CID: 58965404
Max Phase: Preclinical
Molecular Formula: C22H21N3O2
Molecular Weight: 359.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CNC(=O)c1ccc2ncccc2c1)NC1CCCc2ccccc21
Standard InChI: InChI=1S/C22H21N3O2/c26-21(25-20-9-3-6-15-5-1-2-8-18(15)20)14-24-22(27)17-10-11-19-16(13-17)7-4-12-23-19/h1-2,4-5,7-8,10-13,20H,3,6,9,14H2,(H,24,27)(H,25,26)
Standard InChI Key: MBGWYGHZHAXUFZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2995 2.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 3.7467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6385 3.1449 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6034 5.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9042 5.9961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9073 7.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2082 8.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8691 8.0987 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2137 9.7430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5318 10.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5181 7.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8180 8.2339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8248 9.7311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1246 10.4739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4176 9.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4108 8.2221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1110 7.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 23 2 0
22 21 2 0
21 17 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1634AlogP: 3.16#Rotatable Bonds: 4Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.59CX Basic pKa: 4.02CX LogP: 2.81CX LogD: 2.81Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -1.26
References 1. (2007) Tao Kinase Modulators And Method Of Use,